Mammalian blastocysts comprise three distinct lineages, namely, trophoblast, hypoblast, and epiblast, which develop into fetal placenta, extraembryonic yolk sac, and embryo proper, respectively. Pluripotent embryonic stem cells, capable of forming all adult cell types, can only be derived from the epiblast. In mouse and rat, this process is promoted by the double inhibition (2i) of mitogen-activated protein kinase kinase (MAP2K), which antagonizes FGF signaling, and glycogen synthase kinase 3 (GSK3), which stimulates the WNT pathway. We investigated variations of the 2i treatment on lineage segregation and pluripotency-related gene expression in bovine blastocysts. In vitro-fertilized embryos were cultured either in the presence of inhibitors of GSK3 (3 lM CHIR) and MAP2K (0.4 vs. 10 lM PD0325901, designated 2i and 2i+, respectively) or in 2i/2i+ with FGFR inhibitor (0.1 lM PD173074, designated 3i [2i and PD173074] and 3i+ [2i+ and PD173074]). Compared with 2i, both 2i+ and 3i+ potentiated the improvement in blastocyst morphology. Using an automated platform for multiplexed digital mRNA profiling, we simultaneously counted transcripts of 76 candidate genes in bovine blastocysts treated with multiple kinase inhibitors. We show that 2i+ medium specifically increased FGF4 and NANOG while reducing PDGFRalpha and SOX17 levels. The shift from a hypoblast to an epiblast gene expression signature was confirmed by quantitative PCR. A wide range of functionally related genes, including candidates involved in DNA methylation, were not significantly changed. This well-defined 2i+ effect was not observed after pharmacologically inhibiting FGF receptor or related MAP kinases (p38, JNK, and ERK5). In summary, our data suggest that increased MAP2K inhibition exerts its pluripotency-promoting effects through as yet unidentified signals.
INTRODUCTION
Following fertilization, mammalian zygotes develop into blastocysts comprising an outer trophoblast epithelium (TE) and inner cell mass (ICM). The trophoblast gives rise to extraembryonic tissues, whereas the ICM segregates into the epiblast and the hypoblast, two morphologically distinct cell populations that subsequently develop into the embryo proper and the extraembryonic yolk sac, respectively. In mouse, embryonic pluripotent stem cells (ePSCs or ESCs) can also be efficiently derived from the epiblast [1] . The segregation of the two lineages was consolidated using quantitative single-cell gene expression analysis [2] . In 64-cell murine blastocysts, the top three inversely correlated gene pairs within the ICM are 1) fibroblast growth factor (Fgf) 4, Nanog, and Sox2 for the epiblast; and 2) Fgf receptor (Fgfr) 2, Gata6, and Gata4 for the hypoblast. Nanog expression in particular is tightly correlated with the nascent epiblast and is mutually exclusive with the hypoblast marker Gata6 [3] [4] [5] .
Gene deletion studies in mouse have shown that Nanogdeficient embryos fail to generate the epiblast [6] . In these Nanog-null embryos the hypoblast is also lost, but it can be restored by wild-type cells in chimeras. This suggests that hypoblast development depends on signaling from the epiblast. Based on numerous functional studies, FGF4 is the principal candidate for a secreted factor autocrinally produced in epiblast cells [7] . Blastocysts carrying a genetic deletion of Fgf4 or its downstream signaling components do not maintain early hypoblast-specific factors GATA6, PDGFRa, and SOX17, and consequently lack the hypoblast [7] . Conversely, administering exogenous FGF4 to early embryos sustains expression of GATA6, PDGFRa, and SOX17; activates the later hypoblast-specific factors GATA4 and SOX7; and inhibits epiblast-specific NANOG. As a result, the entire ICM forms the hypoblast in a dose-dependent manner [7] . Taken together, continuous FGF4-FGFR2 signaling drives stable epiblast/ hypoblast segregation and regulates the cell number ratio of these two tissues in the mouse embryo.
Secreted FGF4 induces lineage commitment by activating the mitogen-activated protein kinase (MAPK) module, comprising MAPK kinase 1/2 (MAP2K, also known as MAPKK or MEK) and MAPK1/2 (ERK) [8] . Consequently, pharmacological MAP2K inhibition shields epiblast cells from inductive FGF signals and effectively blocks their differentiation. In vivo, this prevents epiblast cells from diverting into extraembryonic lineages, resulting in blastocysts in which all ICM cells become epiblast [9] . WNT proteins also antagonize FGF/ MAP2K and can be indirectly stimulated by partial inhibition of glycogen synthase kinase 3 (GSK3) [10, 11] . The double inhibition (2i) of MAP2K and GSK3 provides chemically defined culture conditions that effectively block exit from pluripotency. Double inhibition medium promotes in vitro propagation of several murine PSC types [12] [13] [14] and enables the derivation of fully pluripotent (''naive'') ePSCs from previously refractory rat embryos [15, 16] . These advances suggest that the naive pluripotent state may be a conserved feature of mammalian embryogenesis that could be captured in cattle and other nonrodent livestock species.
Our understanding of early cell fate determination and pluripotency signaling is mainly based on studies in the mouse. However, different species of placental mammals differ in the timing of developmental milestones, lineage specification, and embryonic/extraembryonic morphology [17] . In bovine, for example, the pregastrulation epiblast is maintained for longer than in mouse (i.e., from Embryonic Days [D] 8-13) [18] [19] [20] . This extended presence is due to the noninvasive mode of placentation, whereby gastrulation does not depend on uterine attachment.
Bovine NANOG appears to first become epiblast restricted and mutually exclusive with the hypoblast marker GATA6 in D8 blastocysts [21] . Similar to NANOG, bovine SOX2 is also progressively limited to the ICM and epiblast [22] . Another crucial pluripotency factor, POUF51 (better known as OCT4), persists for some time in both trophoblast and hypoblast before becoming gradually epiblast exclusive after hatching [23] [24] [25] [26] . Outside the core pluripotency network, markers of naive pluripotency and hypoblast versus epiblast versus trophoblast lineage decisions have not been systematically analyzed in bovine embryos.
Prompted by the robust effects of 2i culture in rodents, we have previously probed the existence of a pluripotent ground state in cattle embryos [27] and short-term ePSC cultures [28] . We found that 2i improves in vitro blastocyst development and quality. Based on a small number of candidate genes, 2i also increased epiblast-specific and repressed hypoblast-specific genes, whereas trophoblast-specific marker expression was not altered. Here, we extend these studies into comprehensively analyzing the effect of multiple kinase inhibitors, targeting different pathways, on a large number of pluripotency-related and lineage-specific genes in bovine blastocysts. We simultaneously quantified 76 candidate genes using the nCounter Analysis System, an automated platform that uses digital bar coding and direct mRNA imaging for multiplexed gene expression assays [29] . We show that increased concentration of MAP2K1/2 inhibitor PD0325901 (2iþ) specifically potentiates NANOG/FGF4 and reduces PDGFRa/SOX17 beyond 2i expression levels. This well-defined 2iþ effect was not observed after pharmacologically inhibiting receptor tyrosine kinase FGFR or other MAPK members. Our data suggest that 2iþ exerts its pluripotency-promoting effects through as yet unidentified signals.
MATERIALS AND METHODS
Chemicals were purchased from Sigma-Aldrich, and all embryo manipulations were carried out at 38.58C unless indicated otherwise. All experiments were direct contemporaneous comparisons; that is, within each IVF run all parameters other than the culture conditions (dimethyl sulfoxide [DMSO] vs. inhibitors) were kept the same.
In Vitro Production of Embryos
In vitro-matured oocytes from slaughterhouse ovaries of mixed-breed dairy cows were fertilized with frozen-thawed semen from a sire with proven in vitro fertility, as described previously [30] . For cumulus-free cultures, the corona was dispersed after in vitro fertilization (IVF) for 22-24 h by vortexing oocytes in 500 ll of 1 mg/ml bovine testicular hyaluronidase in Hepes-buffered SOF (HSOF), followed by two washes in HSOF. For in vitro culture (IVC), 10 embryos were pooled in 20 ll of early SOF medium and cultured for 8 days (Day 0 [D0]: fertilization). On D5, embryos were changed into fresh late SOF drops containing 10 lM 2,4-dinitrophenol [31] . Culture medium was supplemented with 3 lM GSK3B inhibitor CHIR99021 (Stemgent), MAP2K1/2 inhibitor PD0325901 (Stemgent) at 0.4 or 10 lM final concentration (2i or 2iþ, respectively), and 0.1 lM FGFR inhibitor PD173074 (Sigma; 2i and PD173074 [3i] or 2iþ and PD173074 [3iþ]). Other inhibitors included SB202190 (10 mM stock, 5 lM final; Sigma) for MAPK14/ p38, SP600125 (10 mM stock, 10 lM final; Sigma) for MAPK9/JNK, and BIX02189 (10 mM stock, 10 lM final; Selleck Chemicals) for MAP2K5. All inhibitor stocks were dissolved in DMSO, and solvent controls contained the corresponding amount of DMSO in the culture medium. Embryo cultures were overlaid with mineral oil and kept in a humidified modular incubation chamber (ICN Biomedicals Inc.) gassed with 5% CO 2 , 7% O 2 , and 88% N 2 . Embryos were categorized according to developmental stage as early, mid, expanded, or hatched blastocyst (EB, MB, XB, or HB, respectively) and morphologically graded as described previously [32] . All embryos were graded and staged by the same person throughout this study (B.O.).
Differential Staining
Expanded D8 grade 1 and 2 blastocysts (XB [1] [2] ) were treated with pronase to remove the zona pellucida [33] and were exposed to a 1:4 dilution in Hepesbuffered transfer late SOF (THSOF) of rabbit anti-bovine whole serum (B3759; Sigma) for 45 min, rinsed in THSOF with 0.1 mg/ml cold soluble polyvinyl alcohol (THSOF-PVA; M r : 10 to 30 000), and placed for 15 min into a 1:4 dilution in THSOF of guinea pig complement (S1639; Sigma) containing 5 lg/ ml propidium iodide and 40 lg/ml Hoechst 33342. After rinsing in THSOF-PVA, the embryos were mounted (DAKO mounting medium; S3023; Med-Bio Ltd.) on glass slides and examined using an epifluorescence microscope (AX-70; Olympus). Blue and pink colors were designated as ICM and trophectoderm (TE) cells, respectively [34] , and nuclei numbers were counted the same day using ImageJ (version 1.45s; National Institutes of Health).
nCounter Analysis
For each treatment, three pools of 10 grades 1-2 D8 blastocysts were collected (N ¼ 30) from four different IVF runs, washed in PBS/PVA, and snap-frozen in liquid nitrogen. To this, 5 ll of RNAGEM Tissue PLUS (ZyGEM) solution was added, and RNA was extracted with a 758C incubation for 5 min. For shipment to the nCounter service site (nanoString Technologies), 5 ll of RNAstable (Biomatrica) was added and samples were air-dried in a laminar flow hood at ambient temperature overnight. For reconstitution of dried samples, 5 ll of diethyl pyrocarbonate (DEPC)-treated water was added, and samples were incubated at room temperature for 15 min and resuspended by gentle pipetting. The nCounter Analysis System (NanoString Technologies) was used to quantify gene expression of 76 targets associated with early embryonic development and/or pluripotency (Supplemental Table S1 ; Supplemental Data are available online at www.biolreprod. org). Following sequence-specific target enrichment for 10 cycles, customized sequence-specific capture and reporter probes, linked with biotin and a fluorescent bar code, respectively, were hybridized with the preamplified sample according to NanoString's standard protocol. Excess probes were removed and the tripartite complex was immobilized on a streptavidin-coated nCounter cartridge [35] . Individual counts of the fluorescent bar codes were acquired by the nCounter digital analyzer. One 3iþ biological replicate did not pass quality control and was excluded from the analysis. In order to determine true counts and minimize background, the highest of eight unique internal negative control counts for each sample and each gene was subtracted from the raw counts before normalization (Supplemental Table S2 ). Following background subtraction, a subset of probes was excluded as unreliable for quantification. A normalization factor was then calculated based on the product of 1) the geometric mean of four housekeeping genes (GAPDH, HPRT, PPIA, and ACTB) and 2) the averages of the six internal positive controls, exogenous spikes of known mRNA concentration. Each sample's unique normalization factor was then applied to all target gene counts (Supplemental Table S2 ).
RNA Extraction and RT-PCR
Pools of grades 1-2 D8 blastocysts were lysed in either 50 ll of TRIZOL (Life Technologies) or 10 ll of RNAGEM Tissue PLUS (containing 0.5 ll of RNAGEM) and processed following the manufacturer's instructions. For both methods, cDNA was synthesized as described previously [36] . Reverse transcriptase was omitted in one sample each time a batch was processed for cDNA synthesis (ÀRT). Primers were designed using NCBI/Primer-BLAST (Supplemental Table S3 958C); 2) amplification and quantification (10 sec at 958C, 20 sec at 608C, followed by 10 sec at 728C with a single fluorescent measurement repeated 45 times); 3) melting curve (958C, then cooling to 658C for 20 sec, heating at 0.28C sec À1 to 958C while continuously measuring fluorescence); and 4) cooling to 48C. Product identity was confirmed by gel electrophoresis and melting curve analysis. For relative quantification, external standard curves were generated from serial 5-log dilutions for each gene in duplicate. One highefficiency curve (3.6 ! slope ! 3.1; R 2 . 0.99) was saved for each target gene and imported for relative quantification as described previously [36] .
Heat Maps and Volcano Plots
To present data as fold-changes, normalized counts for each treatment were averaged, and log ratios over DMSO were calculated in Excel (Microsoft). Heat maps were constructed in R (version 3.0.1) using the heatmap.2 function from the gplots package. For unsupervised hierarchical clustering, Euclidean distance and different cluster calculation options were used. All resulted in the same groups, and presented results are based on ''average'' clustering. Volcano plots were generated in Excel.
Immunoblotting
Western blot analyses were carried out using the following antibodies: phospho (Thr202/Tyr204)-p44/42 MEK1/2 (no. 9101) and p44/42 MEK1/2 (no. 9102; both Cell Signaling Technologies). Whole, grades 1-2 D8 embryo lysates were resolved on 4%-12% Bis-Tris SDS-PAGE gradient NuPage gels, transferred to nitrocellulose membranes, and blotted for phospho-MAP2K1/2 and MAP2K1/2 (both 1:1000). Both antibodies were previously shown to specifically recognize bovine antigens. The secondary antibody, goat antirabbit immunoglobulin G-horseradish peroxidase (P0448; Dako), was used at 1:5000, and peroxidase activity was visualized with Western Lightning Plus-ECL kit (NEL105001EA; PerkinElmer).
Statistical Analysis
Statistical significance was accepted at P , 0.05 and determined using the two-tailed Fisher exact test for independence in 2 3 2 tables for developmental data or the paired two-tailed Student t-test for cell counts. Logs of nCounter and qPCR gene expression data were analyzed using the residual maximum likelihood method in GenStat (16th edition), with treatments as fixed effects, and run and sample within run as random effects. All values are presented as mean 6 SEM of the log ratios of gene expression relative to the DMSO control, unless indicated otherwise.
RESULTS

2iþ Inhibition Increases Bovine Blastocyst Development and ICM Numbers
Bovine IVF embryos were cultured in the presence of different kinase inhibitor combinations from the morula stage (D5) onward. Compared with vehicle controls, the inclusion of different MAP2K1/2 inhibitor PD032 concentrations (range, 0.04À100 lM) neither improved (Supplemental Fig. S1A ) nor accelerated (Supplemental Fig. S1B ) in vitro development. By contrast, combining 10 lM PD0325901 (PD032þ) with 3 lM CHIR (2iþ) and combining 2iþ with PD173074 (3iþ) increased the formation of morphologically superior blastocysts in vitro (Table 1) . We observed that blastocysts derived in 2iþ or 3iþ medium were recognizable by their exceptional morphological quality. Accordingly, the proportion of grade 1 blastocysts out of the total number of blastocysts was quadrupled in 2iþ medium versus DMSO controls (25 of 252 [9.9%] vs. 6 of 259 [2.3%], respectively; P , 0.01; 14 replicate IVF runs). Our qualitative impression of improved blastocyst development was supported by differential staining (Supplemental Fig. S1C ) and quantification of the number of putative ICM, TE, and total cell nuclei. Under all conditions of kinase inhibition, ICM numbers were significantly increased compared with DMSO (Table 2 ). Concomitant increase in TE numbers was only observed under additional FGFR inhibition (3i/3iþ). Consequently, only 2iþ culture simultaneously increased both morphological quality and ICM:TE ratios.
2iþInhibition Shifts Hypoblast to Epiblast Gene Expression Signature
In order to correlate changes in morphology and cell numbers with changes in lineage segregation, we next analyzed gene expression changes. For this, mRNA molecules were counted with the nCounter Analysis System, an automated platform that uses digital bar coding chemistry for multiplexed transcriptional profiling [29] . We simultaneously quantified 76 pluripotency-related and lineage-specific candidate transcripts in inhibitor-treated blastocysts. Following background subtraction, a subset of probes resulted in negative or near zero values (Supplemental Table S2 ). These genes were excluded as unreliable for quantification: DAZL, FNIP1, NR0B1, RUNX1, WNT3A, WNT5A, WNT10B, and WNT11. Unsupervised hierarchical clustering of 64 informative genes revealed 2i/ 2iþ to clearly segregate from the 3i/3iþ treatments (Supplemental Fig. S2A ). Heat map analysis showed that this grouping was based on a larger number of up-regulated genes upon increasing PD032 concentration, compared with when PD173 was also added (Supplemental Fig. S2B ). In order to compare the size of the gene expression fold-change to statistical significance, we generated volcano plots (Fig. 1A) . These further refined a fingerprint of consistent gene expression changes. PDGFRa, an early hypoblast-specific factor in mouse, was significantly down-regulated (more than 2-to 3-fold) in all inhibitor treatments. Reduction of SOX17, another early hypoblast marker, was even greater (10-fold) in 2iþ. At the same time, epiblast-specific factors NANOG and FGF4 were up-regulated in 2iþ, where they increased .5-fold and .10-fold, respectively. In accordance with the heat map display, 3i/3iþ affected a larger and more diverse group of genes than the 2i/2iþ treatments. Whereas the down-regulation of hypoblast genes was still observed, particularly in 3iþ, upregulation of NANOG and FGF4 was less consistent. In order to substantiate the nCounter results, we followed up the most promising candidates with qPCR (Fig. 1B) . This confirmed robust up-regulation of NANOG and FGF4 (3-and 10-fold, respectively; P , 0.001) and down-regulation of PDGFRa and SOX17 (3-and 10-fold, respectively; P , 0.001 and P , 0.05) in 2iþ. We extended this qPCR validation into a wide range of other pluripotency-or lineage-related genes and confirmed that their levels were mostly not significantly changed (Supplemental Fig. S2C ). This included pluripotency-related factors (BMP4, CDH1, DPPA3, KLF4, TBX3, and TCF3), as well as additional hypoblast (FGFR2, GATA4, and GATA6) and trophoblast (CDX2 and PDGFa) markers. In mouse ePSCs, 2i medium promotes global DNA hypomethylation [37] . This effect is mediated through upregulation of Prdm14, which directly represses expression of de novo DNA methyltransferases Dnmt3 and Dnmt3b, and their cofactor Dnmt3l [37, 38] . We therefore specifically analyzed the bovine homologues of PRDM14, DNMT3A, and DNMT3B. None of these genes showed any significant changes by nCounter or qPCR analyses (Supplemental Fig. 2D ).
Candidate MAP Kinase Blockers Do Not Phenocopy 2iþ Effects
We next addressed the molecular mechanism underlying the observed morphological and gene expression changes. Using the most informative candidates from our nCounter screening, we determined the dependency of NANOG/FGF4 and PDGFRa/SOX17 up-and down-regulation, respectively, on PD032 dosage. For these genes, higher PD032 concentrations (30 and 100 lM) did not further up-regulate NANOG/FGF4 or down-regulate PDGFRa/SOX17, confirming PD032þ as the minimal effective concentration to maximize epiblast lineage bias (Supplemental Fig. S3A ). It also did not affect C-MYC expression across a 2500-fold range of concentrations (Supplemental Fig. S3B ). We then examined how PD032þ affected MAP2K1/2 signaling. In mouse ePSCs, MAPK1/2 phosphorylation is only partially inhibited at 0.4 lM PD0325901 [12] . This is in contrast to cultured bovine embryonic fibroblasts, where 0.4 lM PD0325901 completely abolishes MAP2K1/2 signaling [39] . Similarly to bovine fibroblasts, MAPK1/2 phosphorylation in bovine blastocysts was also already completely abrogated at 0.4 lM PD0325901 and remained so at 10 lM (Supplemental Fig. S3C ). Because the effect of PD032þ was unlikely to be mediated by further suppression of MAP2K1/2 signaling, we investigated potential off-targets. It has been reported that PD0325901 at 0.1 and 10 lM inhibits several other kinases [40] . In order of increasing residual activity after exposure to 0.1 lM or 10 lM PD0325901, these include: 1) MAP2K6, which represses MAPK14 (p38); 2) MAPK9 (JNK2); 3) FGFR1; and 4) MAP2K5, which represses MAPK5 phosphorylation [41] . We cultured bovine embryos in the presence of compounds that specifically inhibit each of these MAPK-dependant pathways, namely, SB202190 (MAPK14/ p38), SP600125 (MAPK9/JNK), PD173074 (FGFR), and BIX02189 (MAP2K5/MEK5). On D8, blastocyst development, morphology, and gene expression were assessed. None of these inhibitors had a significant impact on embryo development (Table 3) , cell numbers (Table 4) , or epiblast-specific gene expression (Fig. 2) . Inhibitors of p38 and JNK, on the other hand, both reduced PDGFRa/SOX17, wheraes blocking FGFR tended to up-regulate NANOG/FGF4. Of all kinase inhibitors tested, only PD032þ improved blastocyst development and enhanced epiblast gene expression, indicating that the 2iþ effect can be partly evoked in the absence of CHIR (Fig. 2) . We conclude that the effects of increased PD032 concentration cannot be phenocopied by a panel of candidate MAP kinases and are likely mediated through as yet unidentified signals. 
2iþ MEDIUM ENHANCES BOVINE EPIBLAST SIGNATURE
DISCUSSION
Effects of Multiple Kinase Inhibition on Bovine ICM Development
Here, we show that fine-tuning the inhibition of MAP2K signaling further improves bovine blastocyst morphology and selectively shifts gene expression from a hypoblast-specific signature toward an epiblast-specific signature. The 2iþ culture regimen increased ICM, but not TE, numbers, either by stimulating proliferation or suppressing cell death. The increase in ICM size was reflected by quadrupled numbers of morphological grade 1 D8 blastocysts. Although a similar effect has been observed before when bovine embryos were cultured to D7 in 2i [27] , it became more obvious when extending embryo culture to D8. PD173 and PD032 alone (the current study, and Harris et al. [27] ) did not affect ICM size. On the other hand, ICM cell numbers were increased after exposure to 2i/3i and 2iþ/3iþ combinations as well as CHIR alone [27] , with no significant differences between these treatments. Thus, bovine embryos do not depend on FGF/ MAPK signaling for sustained proliferation and growth, and may even be restricted by it.
Because MAP2K and GSK3 inhibitors independently increased cell numbers to a similar extent, all of these treatments may converge on the same signaling pathway to augment cell proliferation and viability. A candidate that might have been causing this effect was C-MYC, a potent oncogene and driver of anabolic activity in the murine epiblast [42] . MYC functions are distinct from the core pluripotency factors and are mainly associated with protein metabolism [43] . Contrary to mouse ePSCs, where PD032 reduces C-MYC levels [12] , we observed no changes in C-MYC mRNA expression upon PD032 exposure (the current study) or 2i exposure [27] . Nevertheless, stabilization of C-MYC protein (e.g., as a result of partial GSK3 inhibition) cannot be excluded. From a practical perspective, it remains to be determined whether the greater yield of high-quality in vitro-produced blastocysts will translate into a larger number of viable calves after embryo transfer. FGF4) and hypoblast (PDGFRa, SOX17) genes. Complementary DNA was extracted from pools of grades 1-2 D8 blastocysts cultured in DMSO-containing versus inhibitorcontaining medium. Target gene values were normalized on 18S expression and expressed as fold-change over DMSO control. *P 0.05, **P , 0.01 difference from DMSO control.
2iþ Enhances Epiblast Gene Expression Signature
In late mouse blastocysts, pharmacological inhibition of Fgf/Mapk signals, either by PD032 or PD173 alone or by 2i/3i, eliminated Gata4 expression and expanded Nanog expression [9] . This happened without changes, or even with a slight increase, in ICM size, suggesting that hypoblast cells become redirected toward epiblast fate. We previously demonstrated that bovine IVF embryos and ePSCs also benefit from culture in 2i [27, 28] . However, the effect was modest compared with mouse, indicating species-specific signaling differences in the molecular circuitry governing the pluripotent state. As with most studies of embryonic lineage decisions, our analyses were restricted to a handful of candidate lineage markers that can be conveniently quantified by qPCR in small pools of embryos. In order to maximize the amount of gene expression information extracted from limiting embryo samples, we used the automated nCounter platform for multiplexed digital mRNA profiling. This system enabled comprehensive quantification of the embryonic response to multiple kinase inhibitors. We counted transcripts of 76 candidate genes, including 4 housekeeping controls, in 150 bovine blastocysts (3 3 10 embryos per treatment). Collectively, these genes have proven informative regarding early cell fate decision in mouse [2] and bovine [44, 45] blastocysts. Whenever they were available in bovine, we focused on genes associated with acquisition [46] or exit [47] from naive pluripotency in mouse ESCs. In addition, we included various secreted cytokines of the WNT family as potential signaling agonists of pluripotency [11] . In total, only eight genes were not detectable above background levels, including several WNTs (WNT3A, WNT5A, WNT10B, and WNT11), a hypoblast (RUNX1), and a PGC (DAZL) marker, as well as pluripotency agonists (NR0B1) and antagonists (FNIP1). Thus, the largely mouse-derived expression signature was robustly conserved in cattle and is informative for pharmacological perturbation studies.
In our data set, abundance of individual mRNA molecules spanned five orders of magnitude (from 10 1 to 10 5 digital counts), providing a wide dynamic range of biological expression levels and increasing the detection of lowabundance mRNAs. Some epiblast markers (FGF4) and hypoblast transcription factors (GATA4/6, SOX17) were among the rarest transcripts (,10 3 counts in DMSO controls). This may explain why they were either not detected in a microarray study of bovine blastocysts [44] or not recognized as ICM specific by global RNA-seq analysis [45] . By contrast, trophoblast marker Krt8, the most abundant mRNA within our set (.10 5 counts), was clearly identified by both previous microarray [44] and RNA-seq [45] . Given the low estimated amount of starting material (;2 ng of total RNA), target transcripts were reverse transcribed and simultaneously amplified for 10 cycles to allow for linear target enrichment. The fold-change data obtained from nCounter analysis correlated well with qPCR results. Moreover, the multiplexing capabilities of nCounter extended our ability to obtain data at qPCR levels of sensitivity. Unlike high-throughput real-time qPCR systems, such as the Fluidigm platform, the nCounter required only a single reaction per multiplexed sample, further reducing experimental variation. The system is therefore well suited for high-throughput screening (e.g., of small molecules) using genetic regulatory networks of low-copy transcription factors as read-out. In this context, we have successfully applied this platform to smaller pools of bisected blastocyst samples and even single embryos (Z. McLean, unpublished observations). Of great interest is the recent adaptation of nCounter technology for multiplex protein profiling [48] . This opens up the possibility for simultaneous analyses of geneprotein levels from the same biological material.
We analyzed 41 putative epiblast/pluripotency, 8 hypoblast, and 7 trophoblast markers. From these, only a small subset of epiblast (FGF4/NANOG) and hypoblast (PDGFRa/SOX17) candidates was significantly altered. Mouse embryos treated with 10 lM FGFR inhibitor SU5402 displayed an overall similar response, even though the up-regulation of epiblast markers and down-regulation of hypoblast markers were more widespread [2] . This could simply be due to FGFR inhibition blocking downstream signaling pathways other than MAP2K.
Alternatively, it may reflect species-specific differences in the transcriptional wiring of fate-determining transcription factors. One crucial finding of our study was that MAP2K inhibition greatly amplified FGF4 expression. This increase was greater than for other epiblast-restricted factors, such as NANOG. The increase was specific to the ICM because we did not detect any FGF4 mRNA in the TE (data not shown). In global gene expression studies of mouse ePSCs, FGF4 was not among the transcripts increased by 2i [46] . In mouse [9] , bovine [21, 27] , and human [49] embryos cultured with FGF/ MAP2K inhibitors, FGF4 levels were not reported. During normal mouse development, restriction of FGF4 transcripts to a subset of early ICM cells precedes that of NANOG and GATA6, suggesting that FGF signaling is upstream of both lineage specifiers [2] . This initial up-regulation of FGF4 is likely mediated by SOX2 (together with OCT4), the earliest marker of prospective ICM cells in mouse embryos [2] . In this model, elevated SOX2 levels would activate FGF4 transcription [50] . Direct linkage between these two factors is also supported by the observation that SOX2 directly binds FGF4 in mouse ePSCs [51] . Even though SOX2 was not picked up as a candidate in our nCounter experiments, we have previously found its mRNA significantly up-regulated by 2i in D7 ICM cells [27] , indicating that it may be partly responsible for increased FGF4 expression. At the same time, SOX2 could also maintain the expression of key pluripotency SOX2 target genes, such as NANOG [52] , whose expression closely tracked with FGF4.
The consequences of up-regulated FGF4 mRNA levels are unclear. It first needs to be demonstrated that this results in increased levels of FGF4 secreted from ICM cells. If protein levels were indeed elevated, signaling through the FGFR could, in principle, be relayed through four parallel pathways, namely, 1) JAK/STAT, 2) PI3K, 3) PLCc, and 4) MAPK [7] . From these, the MAPK circuit is blocked under PD032 or 2i conditions, whereas the remaining pathways remain to be tested. We have thus uncovered an autoregulatory negative feedback loop, whereby FGF-induced MAPK activity normally limits FGF signaling in the bovine embryo.
Compared with 2i, both PD032þ and 2iþ further potentiated autocrine FGF4 expression. Because MAP2K phosphorylation was already abolished by standard PD032 concentrations, PD032þ likely targeted additional autoregulatory repressors. We therefore tested candidates from the three other MAP kinase groups, namely, p38, JNK, and MAP2K5, for their ability to induce FGF4. Some of these inhibitors (p38 i , JNK i ) have recently been included in a complex inhibitor cocktail that promotes a naive-like state in human PSCs [53] . However, in our single-inhibitor screen, none of the other MAPK blockers affected development, ICM numbers, or FGF4/NANOG expression.
Increased MAP2K inhibition in bovine embryos was tightly correlated with increased NANOG levels. This is similar to the situation in mouse, where Fgf4 expression is restricted to NANOG-positive cells and not detected in Nanog mutants 2iþ MEDIUM ENHANCES BOVINE EPIBLAST SIGNATURE [54] . Thus, Fgf4 expression depends on the presence of NANOG. Vice versa, FGF4/MAPK signals selectively repress NANOG gene transcription in ePSCs [55] . This repression can be rapidly and specifically reversed by chemical FGFR, but not PI3K or JNK, signal inhibition [55] [56] [57] . Our results support and extend these findings by showing that inhibiting p38, JNK, and MAP2K5 did not up-regulate NANOG.
Depending on the sequence conservation between mouse versus bovine, NANOG activation would establish pluripotency in the ICM through activating its target genes, such as ESRRB, KLF4, ZFP42, TBX3, and PRDM14 [58] and repressing GATA6 [56] . Surprisingly, 2iþ did not significantly affect any of these factors. This was unexpected, because ectopic NANOG, if translated into ectopic protein, should have, for example, directly activated ESRRB [58] or repressed GATA6 [54] in inhibitor-treated embryos. Because we could not experimentally dissociate NANOG expression from FGF/ MAPK inhibition (e.g., by using NANOG mutants), we did not further address the mechanism of its downstream regulation. Nevertheless, our results suggest that at the late blastocyst stage, expression of bovine GATA6 does not solely depend on direct FGF/MAPK activation, or on indirect activation via inhibiting NANOG-mediated repression.
By contrast, PDGFRa and SOX17 were strongly repressed once NANOG repression was relieved. As previously observed [27] , GATA4 showed a similar trend, even though this did not appear to be caused by down-regulation of GATA6. In mouse hypoblast cells, Pdgfra, Sox17, Gata4, and eventually Gata6 all lie downstream of MAPK [59] . SOX17 is not required for initial expression of PDGFRa and GATA4 [60] . A similar circuit appears to operate in bovine, where MAPK inhibition simultaneously inhibited expression of multiple hypoblast genes. In support of our data, exogenous FGF2 also stimulated bovine hypoblast proliferation [61] , whereas blocking its signaling decreased GATA4 expression [61] , although this was not apparent on the protein level [21] . Despite their genetic redundancy, these hypoblast genes appear at different time points during mouse development [54] . It remains to be determined whether this chronological order is conserved in bovine and how these factors regulate each other's expression.
NANOG is a serine/threonine phosphoprotein. In mouse ePSCs, this modification prevents its proteasome-mediated degradation [62, 63] . In addition to stabilizing the protein, it is also important for ePSCs self-renewal and functional pluripotency [63] . Interestingly, human NANOG is phosphorylated by MAP2K2 at the homologous site, providing a putative link between signaling and pluripotency [64] . This site, and the surrounding serine/threonine-rich region, is also 100% identical in several livestock species, including goat, sheep, horse, and pig. Whether inhibiting MAP2K reduces this modification and how this would affect NANOG stability and contribute to lineage specification in the blastocyst is not known. Even though inhibiting other MAP kinases, namely, MAPK14, MAPK9, and MAP2K5, did not increase NANOG expression, we cannot exclude that they modify NANOG.
2iþ Does Not Affect Trophoblast Signature
Increased MAPK inhibition did not impair trophoblast proliferation, marker expression, lineage specification, and blastocoel formation in cultured cattle embryos. A similar effect was previously observed for 2i in bovine embryos and ePSCs [27, 28] . This is consistent with studies showing that isolated trophoblast cells did not require FGF to survive, proliferate, and maintain CDX2 expression [61, 65, 66] . In mouse, a range of trophoblast markers, including Cdx2, Gata3, and Krt8, were also unaffected by FGFR inhibition [2] ; however, trophoblast cell proliferation was reduced by 2i or MAPK inhibition [9] .
In conclusion, we have shown that adjusting inhibition of MAP2K signaling further improves bovine blastocyst morphology in vitro and selectively promotes an epiblast-specific gene expression signature. These findings suggest that even though the basic molecular mechanisms governing early lineage segregation are conserved between mouse and cattle, subtle differences also exist. These differences relate to a divergent response to kinase inhibition and may underlie the continuous challenge of deriving naive PSCs from livestock embryos without genetic intervention.
